Dyslipidemia News and Research

RSS

Dyslipidemia is a disruption in the amount of lipids in the blood.

Obesity rate among American workers of all ages grew from 20% to 29% over the past decade

The obesity rate among American workers of all ages grew from 20% to 29% over the past decade, leading to serious repercussions in the workplace and a demand for solutions, according to a new Pfizer Inc study published today in the Journal of Occupational and Environmental Medicine.

13 Dec 2004

Weight loss surgery reduces components of metabolic syndrome in obese patients

Obese patients who underwent surgical treatment for weight loss had significant reductions in the components of the metabolic syndrome one year after surgery, according to an article in the October issue of The Archives of Surgery.

18 Oct 2004

Ezetrol co-administration with statin therapy lowers LDL cholesterol in diabetics

Results from two new clinical trials show that patients with diabetes and metabolic syndrome who are treated with ezetimibe (EZETROL®) co-administered with a statin experience greater reductions in LDL (“bad”) cholesterol, compared to patients taking a statin alone.

7 Sep 2004

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

Having three or more traits of the metabolic syndrome significantly increases the risk of dying from coronary heart disease, cardiovascular disease or any other cause, according to a study in Circulation: Journal of the American Heart Association.

25 Aug 2004

Clinical trial of lipase inhibitor for the treatment of obesity

Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability and pharmacokinetics of GT389-255, a lipase inhibitor conjugated to a fat binding polymer for the treatment of obesity.

9 Aug 2004

Nearly 50 million U.S. adults have hypertension, more than two-thirds of them also have high cholesterol

People who have high blood pressure are highly likely to also have untreated or insufficiently treated cholesterol problems that significantly increase their risk for heart attack and stroke

29 Jun 2004

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride decreases and high-density lipoprotein (HDL) cholesterol increases that demonstrated statistically significant improvements from baseline.

30 Apr 2004

Dyslipidemia News and Research

Obesity rate among American workers of all ages grew from 20% to 29% over the past decade

Weight loss surgery reduces components of metabolic syndrome in obese patients

Ezetrol co-administration with statin therapy lowers LDL cholesterol in diabetics

New study confirms benefits of rimonabant in weight loss

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

Clinical trial of lipase inhibitor for the treatment of obesity

Nearly 50 million U.S. adults have hypertension, more than two-thirds of them also have high cholesterol

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News